Our studies found that MEA1 negatively correlated with the abundance of most immune cells upregulated in tumor tissue and the results of various pathways, including gastric cancer, breast cancer, basal cell carcinoma, and downregulated translation repressor activity. This evidence concerns the gene MEA1 and breast carcinoma.